FACT II Acquisition Corp. (NASDAQ:FACTU) announced the pricing of its $175 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “FACTU”, Tuesday, November 26, 2024.
The new SPAC intends to conduct a broad search and combine with a target company that has demonstrated operating expertise over the past two years with a focus on growing revenues.
FACT II’s sponsor team is led by Chief Executive Officer and Director Adam Gishen and Chief Financial Officer Min Lee. Robert Rackind, Nell Cady-Kruse, James Rallo, and Hella Alashkar will serve on its Board of Directors.
Total SPAC deal count for 2024 year-to-date is now 50. This offering is expected to close on Wednesday, November 27, 2024.
Cohen & Company Capital Markets, a division of J.V.B. Financial Group, LLC, is acting as lead book-running manager, and Seaport Global Securities is acting as joint book runner. Paul Hastings LLP is serving as Issuer’s Counsel with Greenberg Traurig LLP serving as Underwriter’s Counsel. WithumSmith+Brown, PC serves as auditor. Odyssey Transfer and Trust Company is acting as trustee.
At the SPAC of Dawn Amid a restive market, SPACs have front-loaded their business this week with three of their four votes set for today and tomorrow. One of these is a completion vote, in which Bowen (NASDAQ:BOWN) will try and secure shareholder approval for its combination with Shenzhen Qianzhi BioTechnology just after having gained...
Terms Tracker for the Week Ending January 10, 2025 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. This was the first full week in January and the first non-holiday week since December 23rd. All the same, 2025 has started with a bang...
Origin Investment Corp I has filed for a $60 million SPAC to hunt for an Asian target outside of China and marks ThinkEquity’s entry into the 2025 SPAC IPO market. ThinkEquity took all of 2024 off from directly underwriting SPACs as a left lead and has not brought one all the way to IPO since...
Rarely does a group of companies go through a complete industry-defining roller coaster in a matter of weeks based on the comments of two CEOs not of their direct subsector, but that is exactly the kind of winter that quantum computing companies are having. And, despite the recent valley that followed the spike, the three...
At the SPAC of Dawn The markets return from their short funeral break still in the red, but the 8:30 am ET dropping of employment and wage indicators could make this a harder or softer return to business. Drugs Made In America (NASDAQ:DMAAU) is expected to make its debut during this session as the year’s...